Clinical Trial Update: Anti-Schistosomiasis Sm14-vaccine in Senegal [Phase 2]

View source ↗

Summary

Phase 2 trial update for the Sm14 vaccine targeting schistosomiasis in Senegal; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis Haematobium
• Schistosomiasis Mansoni

Drugs mentioned

• sm14 vaccine (sm14)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Schistosomiasis Mansoni, Schistosomiasis Haematobium | Phase 2 | Status: UNKNOWN